SEARCH

SEARCH BY CITATION

References

  • 1
    Ferlay J, Shin HR, Bray F, Forman D, Parkin DM. GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer, 2010. Available at http://globocan.iarc.fr.
  • 2
    National Office for Cancer Prevention and Control of Chinese Ministry of Health. Investigate for malignant tumour mortality in China. Beijing: People's Medical Publishing House Beijing, 1979.
  • 3
    National Office for Cancer Prevention and Control of Chinese Ministry of Health. Shanghai: China Map Press, 1979.
  • 4
    National Office for Cancer Prevention and Control of Chinese Ministry of Health. Investigate for malignant tumour mortality in China (1990–1992). Beijing: People's Medical Publishing House, 2008.
  • 5
    Chen Z. The Third National Retrospective Sampling Death Survey. Beijing, China: Peking Union Medical University Press, 2008.
  • 6
    Editorial. Women's health in rural China. Lancet 2009; 374: 358.
  • 7
    Statistics websites of Chinese central and local governments. Population data and the GDP per capita in China. Available at http://www.stats.gov.cn/. 20–9-2010.
  • 8
    Belinson J, Qiao YL, Pretorius R, Zhang WH, Elson P, Li L, Pan QJ, Fischer C, Lorincz A, Zahniser D. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001; 83: 439444.
  • 9
    Belinson JL, Qiao YL, Pretorius RG, Zhang WH, Rong SD, Huang MN, Zhao FH, Wu LY, Ren SD, Huang RD, Washington MF, Pan QJ, et al. Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology. Int J Gynecol Cancer 2003; 13: 81926.
  • 10
    Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl B, Zhang WH, Peck RB, Li L, Chen F, Pan QJ, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol 2008; 9: 92936.
  • 11
    Zhao FH, Hu SY, Wang SM, Chen F, Zhang X, Zhang WH, Pan QJ, Qiao YL. Association between high-risk human papillomavirus DNA load and different histological grades of cervical neoplasia. Zhonghua Yu Fang Yi Xue Za Zhi 2009; 43: 56570.
  • 12
    Bao YP. The study of human papillomavirus (HPV) type-distribution in cervix of women from Yangcheng County, Shanxi Province and Meta-analysis of HPV Type-distribution in cervix of women in China and Asia. Peking Union Medical College, 2007.
  • 13
    Moy LM, Zhao FH, Li LY, Ma JF, Zhang QM, Chen F, Song Y, Hu SY, Balasubramanian A, Pan QJ, Koutsky L, Zhang WH, et al. Human papillomavirus testing and cervical cytology in primary screening for cervical cancer among women in rural China: comparison of sensitivity, specificity, and frequency of referral. Int J Cancer 2010; 127: 64656.
  • 14
    Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJ, Huang RD, Sun LX, Meijer CJ, Qiao YL, Franceschi S. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Brit J Cancer 2006; 95: 96101.
  • 15
    Yang L, Parkin DM, Li L, Chen Y. A comparison of the sources of cancer mortality in China. Cancer Causes Control 2004; 15: 681687.
  • 16
    International Agency for Research on Cancer. WHO mortality database extracted from the World Health Organization (WHO) Databank. 2005. Available at http://www-dep.iarc.fr/ (accessed on 1-10-2010).
  • 17
    Parkin DM, Whelen SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents, vol. 8. Lyon, France: IARC Scientific Publications, 2002.
  • 18
    Curado MP, Edwards B, Shin HR, Storm H, Frelay J, Heanue M, Boyle P. Cancer incidence in five continents, vol. 9. Lyon, France: IARC, 2007.
  • 19
    Yang L, Parkin DM, Li L, Chen Y. Sources of information on the burden of cancer in China. Asian Pacific J Cancer Prev 2003; 4: 2330.
  • 20
    Zhang SW, Chen WQ, Kong LZ, Li LD, Lu FZ, Li GL. An analysis of cancer incidence and mortality from 30 cancer registries in China, 1998–2002. Bull Chin Cancer 2006; 15: 439448.
  • 21
    Chen WQ. Estimation of cancer incidence and mortality in China in 2004–2005. Zhonghua Zhong Liu Za Zhi 2009; 31: 6648.
  • 22
    Zhang SW, Chen WQ, Kong LZ, Li GL, Zhao P. An annual report: cancer incidence in 35 cancer registries in China, 2003. Bull Chin Cancer 2007; 16: 494507.
  • 23
    Chen WQ, Zhang SW, Kong LZ, Li GL, Zhao P. An annual report: cancer mortality in 35 cancer registries in China, 2003. Bull Chin Cancer 2007; 16: 58697.
  • 24
    Zhang SW, Chen WQ, Lei ZL, Zou XN, Zhao P. A report of cancer incidence from 37 cancer registries in China, 2004. Bull Chin Cancer 2008; 17: 90912.
  • 25
    Chen WQ, Zhang SW, Kong LZ, Lei LZ, Zhao P. Cancer Mortality Report of 34 Cancer Registries in China, 2004. China Cancer 2008; 17: 913916.
  • 26
    Zhang SW, Lei ZL, Li GL, Zou XN, Chen WQ, Zhao P. A report of cancer incidence and mortality from 34 cancer registries in China, 2005. China Cancer 2009; 18: 9739.
  • 27
    Zhang SW, Lei ZL, Li GL, Zou XN, Zhao P, Chen WQ. A report of cancer incidence and mortality from 34 cancer registries in china, 2006. China Cancer 2010; 19: 35665.
  • 28
    Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat. World Population Prospects, the 2008 Revision. 2010. Available at http://esa.un.org/unpp.
  • 29
    International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer 2006;119:110824.
  • 30
    International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, Berrington de González A, Colin D, Franceschi S, Goodhill A, Green J, Peto J, Plummer M, Sweetland S. “http://www.ncbi.nlm.nih.gov/pubmed/17993361Cervical cancer and hormonal contraceptives: collaborative reanalysis of individual data for 16,573 women with cervical cancer and 35,509 women without cervical cancer from 24 epidemiological studies. Lancet 2007; 370: 160921.
  • 31
    McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008; 9: 42534.
  • 32
    Maucort-Boulch D, Franceschi S, Plummer M; IARC HPV Prevalence Surveys Study Group. International correlation between human papillomavirus prevalence and cervical cancer incidence. Cancer Epidemiol Biomarkers Prev 2008; 17: 71720.
  • 33
    Parkin DM, Ferlay J, Hamdi-Cherif M, Itas F, Homas JO, Abinga H, Helan SL. Cancer in Africa: epidemiology and prevention. Cervix cancer. Lyon, France: IARC Press, 2003. 26876.
  • 34
    Rajkumar R, Sankaranarayanan R, Esmi A, Jayaraman R, Cherian J, Parkin DM. Leads to cancer control based on cancer patterns in a rural population in South India. Cancer Causes Control 2000; 11: 4339.
  • 35
    United Nations. UN data, a world of information: Total fertility rate. 2010. Available at http://data.un.org/Data.aspx?d=PopDiv&f=variableID%3A54 (accessed on 15–3-2010).
  • 36
    Li N, Shi JF, Franceschi S, Zhang WH, Dai M, Liu B, Zhang YZ, Li LK, Wu RF, De VH, Plummer M, Qiao YL, Clifford G. Different cervical cancer screening approaches in a Chinese multicentre study. Br J Cancer 2009; 100: 5327.
  • 37
    Belinson JL, Hu S, Niyazi M, Pretorius RG, Wang H, Wen C, Smith JS, Li J, Taddeo FJ, Burchette RJ, Qiao YL. Prevalence of type-specific human papillomavirus in endocervical, upper and lower vaginal, perineal and vaginal self-collected specimens: implications for vaginal self-collection. Int J Cancer 2010; 127: 11517.
  • 38
    Dondog B, Clifford GM, Vaccarella S, Waterboer T, Unurjargal D, Avirmed D, Enkhtuya S, Kommoss F, Wentzensen N, Snijders PJ, Meijer CJ, Franceschi S, et al. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study. Cancer Epidemiol Biomarkers Prev 2008; 17: 173138.
  • 39
    Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, Oladepo O, Smith JS, Arslan A, Munoz N, Snijders PJ, Meijer CJ, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004; 90: 63845.
  • 40
    Sukvirach S, Smith JS, Tunsakul S, Munoz N, Kesararat V, Opasatian O, Chichareon S, Kaenploy V, Ashley R, Meijer CJ, Snijders PJ, Coursaget P, et al. Population-based human papillomavirus prevalence in lampang and songkla, Thailand. J Infect Dis 2003; 187: 124656.
  • 41
    Matos E, Loria D, Amestoy GM, Herrera L, Prince MA, Moreno J, Krunfly C, Van Den Brule AJ, Meijer CJ, Munoz N, Herrero R. Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis 2003; 30: 5939.
  • 42
    Franceschi S, Rajkumar R, Snijders PJ, Arslan A, Mahe C, Plummer M, Sankaranarayanan R, Cherian J, Meijer CJ, Weiderpass E. Papillomavirus infection in rural women in southern India. Br J Cancer 2005; 92: 6016.
  • 43
    Keita N, Clifford GM, Koulibaly M, Douno K, Kabba I, Haba M, Sylla BS, van Kemenade FJ, Snijders PJ, Meijer CJ, Franceschi S. HPV infection in women with and without cervical cancer in Conakry, Guinea. Br J Cancer 2009; 101: 2028.
  • 44
    Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005; 191: 17961807.
  • 45
    Pham TH, Nguyen TH, Herrero R, Vaccarella S, Smith JS, Nguyen TT, Nguyen HN, Nguyen BD, Ashley R, Snijders PJ, Meijer CJ, Munoz N, et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 2003; 104: 213220.
  • 46
    Zhao FH, Xu LN, Hong Y, Niyazi M, Gao XH, Ju LR, Zhang LQ, Feng XX, Duan XZ, Qiao YL. A multi-center survey on age of sexual debut in Chinese women: suggestions for optimal age of HPV vaccination in China. Presented at the 26th International Papillomavirus Conference and Clinical Workshop, Montreal, Canada, 2010. 722.
  • 47
    Xiao L, Yang J, Wan X, Yang GH. What is the prevalence of smoking in China. Zhonghua Liu Xing Bing Xue Za Zhi 2009; 30: 3033.
  • 48
    Zhao FH, Hu SY, Zhang SW, Chen WQ, Qiao YL. Cervical cancer mortality in 2004–2005 and changes during last 30 years in China. Zhonghua Yu Fang Yi Xue Za Zhi 2010; 44: 40812.
  • 49
    Wu RF, Dai M, Qiao YL, Clifford GM, Liu ZH, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Franceschi S. Human papillomavirus infection in women in Shenzhen City, People's Republic of China, a population typical of recent Chinese urbanisation. Int J Cancer 2007; 121: 130611.
  • 50
    Li LK, Dai M, Clifford GM, Yao WQ, Arslan A, Li N, Shi JF, Snijders PJ, Meijer CJ, Qiao YL, Franceschi S. Human papillomavirus infection in Shenyang City, People's Republic of China: a population-based study. Br J Cancer 2006; 95: 159397.
  • 51
    Qiao YL, Franceschi S, Belinson JL, Wei LH, Xu AD, Li CQ, Niyazi M, Ren SD, Li LK, Wu RF, Huang RD, Smith JS. HPV Prevalence in Chinese women: a population-based multiple center survey in Mainland China. Presented at the 24th International Papillomavirus Conference and Clinical Workshop, Beijing, China, 2007.